However, there were constraints on the availability of raw materials and other essential inputs for Remdesivir. “It is difficult to predict the trend of the pandemic and, therefore, difficult to forecast the demand for Remdesivir with a reasonable degree of certainty. The prices of Remdesivir have gone down by 25% to 50%, it noted. Another 1,200 vials have been kept for Central allocation by the Health Ministry, it pointed out. The DCGI (Drugs Controller General of India) has instructed State Drugs Controllers (SDCs) to conduct a special investigation drive to prevent hoarding/black marketing of Remdesivir.

Source: The Hindu May 10, 2021 11:48 UTC